- |||||||||| NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Tracking Neurodegeneration in Early Wolfram Syndrome (clinicaltrials.gov) - Jul 11, 2018 P=N/A, N=101, Completed, Active, not recruiting --> Completed | N=150 --> 101 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: PAIR Study-PAP And IOP Relationship: Study 1 (clinicaltrials.gov) - Jun 7, 2018
P=N/A, N=46, Terminated, Active, not recruiting --> Completed | N=150 --> 101 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017 N=90 --> 46 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Jan 2018; After recruiting just over 50% of target an interim review conclude a larger sample size was highly unlikely to alter the study outcomes
- |||||||||| Enrollment closed, Trial completion date, Trial primary completion date: Tracking Neurodegeneration in Early Wolfram Syndrome (clinicaltrials.gov) - May 1, 2018
P=N/A, N=150, Active, not recruiting, N=90 --> 46 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Jan 2018; After recruiting just over 50% of target an interim review conclude a larger sample size was highly unlikely to alter the study outcomes Recruiting --> Active, not recruiting | Trial completion date: Apr 2017 --> Apr 2018 | Trial primary completion date: Apr 2017 --> Apr 2018
- |||||||||| Trial completion, Trial primary completion date, Gene therapy, Viral vector: Gene Therapy for Blindness Caused by Choroideremia (clinicaltrials.gov) - Nov 17, 2017
P1/2, N=14, Completed, Not yet recruiting --> Completed | N=110 --> 138 | Initiation date: Nov 2015 --> Mar 2017 | Trial primary completion date: Dec 2015 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Feb 2017 --> Oct 2017
- |||||||||| Enrollment closed, Trial primary completion date, Gene therapy, Viral vector: Gene Therapy for Blindness Caused by Choroideremia (clinicaltrials.gov) - Mar 18, 2016
P1/2, N=14, Active, not recruiting, Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2017
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Retinol Equivalence of Plant Carotenoids in Children (clinicaltrials.gov) - Feb 27, 2016 P=N/A, N=32, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2017 Recruiting --> Completed
- |||||||||| Trial completion: BETASNP2: Effect of SNPs in the BCMO1 Enzyme (clinicaltrials.gov) - Oct 6, 2015
P=N/A, N=85, Completed, Recruiting --> Withdrawn | Trial primary completion date: Jul 2015 --> Jan 2015 Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Computer Vision System for the Blind Veteran (clinicaltrials.gov) - Nov 25, 2014
P1, N=60, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2012 --> Dec 2013
|